lobbying_activities: 3231165

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3231165	33ab68a9-45ff-4778-bc10-bebdbf30b04a	3T	TODD STRATEGY GROUP	401103321	CEPHEID	2024	third_quarter	HCR	Antimicrobial resistance. Discussions concerning the FY 2024 appropriations bills; provisions related to HCV Elimination Program Point of Care diagnostic testing.	HOUSE OF REPRESENTATIVES,SENATE	20000		0	1	2024-09-16T16:30:00-04:00